111 related articles for article (PubMed ID: 12402419)
1. [Clinical significance for detection of circulating cancer cells in renal cell carcinoma].
Uemura H; Hirao Y
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1712-8. PubMed ID: 12402419
[TBL] [Abstract][Full Text] [Related]
2. [Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 in patients with renal cell carcinoma].
Hioki T; Sugimura Y
Hinyokika Kiyo; 1999 Aug; 45(8):577-81. PubMed ID: 10500966
[TBL] [Abstract][Full Text] [Related]
3. [Molecular detection of circulating cancer cells in patients with renal cell carcinoma].
Uemura H
Hinyokika Kiyo; 1999 Aug; 45(8):571-5. PubMed ID: 10500965
[TBL] [Abstract][Full Text] [Related]
4. Detection of carbonic anhydrase-9 gene expression in peripheral blood cells predicts risk of disease recurrence in patients with renal cortical tumors.
Gilbert SM; Whitson JM; Mansukhani M; Buttyan R; Benson MC; Olsson CA; Sawczuk IS; McKiernan JM
Urology; 2006 May; 67(5):942-5. PubMed ID: 16698354
[TBL] [Abstract][Full Text] [Related]
5. The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9.
McKiernan JM; Buttyan R; Bander NH; de la Taille A; Stifelman MD; Emanuel ER; Bagiella E; Rubin MA; Katz AE; Olsson CA; Sawczuk IS
Cancer; 1999 Aug; 86(3):492-7. PubMed ID: 10430258
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by RT-PCR.
Clarke LE; Leitzel K; Smith J; Ali SM; Lipton A
Int J Oncol; 2003 Feb; 22(2):425-30. PubMed ID: 12527944
[TBL] [Abstract][Full Text] [Related]
7. Detection of circulating tumor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosis.
Bluemke K; Bilkenroth U; Meye A; Fuessel S; Lautenschlaeger C; Goebel S; Melchior A; Heynemann H; Fornara P; Taubert H
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2190-4. PubMed ID: 19661076
[TBL] [Abstract][Full Text] [Related]
8. Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma.
Cho M; Uemura H; Kim SC; Kawada Y; Yoshida K; Hirao Y; Konishi N; Saga S; Yoshikawa K
Br J Cancer; 2001 Aug; 85(4):563-7. PubMed ID: 11506497
[TBL] [Abstract][Full Text] [Related]
9. Detection of circulating MN/CA9 positive renal cell carcinoma cells during operation.
Uemura H; Nakagawa Y; Iwai A; Okajima E; Okajima E; Yoshikawa K; Hirao Y
Aktuelle Urol; 2003 Jul; 34(4):270-2. PubMed ID: 14566683
[TBL] [Abstract][Full Text] [Related]
10. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
[TBL] [Abstract][Full Text] [Related]
11. Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood.
Roncella S; Ferro P; Bacigalupo B; Pronzato P; Tognoni A; Falco E; Gianquinto D; Ansaldo V; Dessanti P; Fais F; Rosai J; Fedeli F
J Exp Clin Cancer Res; 2005 Jun; 24(2):265-71. PubMed ID: 16110760
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
[TBL] [Abstract][Full Text] [Related]
13. The use of MN/CA9 gene expression in identifying malignant solid renal tumors.
Li G; Cuilleron M; Cottier M; Gentil-Perret A; Lambert C; Genin C; Tostain J
Eur Urol; 2006 Feb; 49(2):401-5. PubMed ID: 16387417
[TBL] [Abstract][Full Text] [Related]
14. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer.
Nakashima S; Natsugoe S; Matsumoto M; Miyazono F; Nakajo A; Uchikura K; Tokuda K; Ishigami S; Baba M; Takao S; Aikou T
Surgery; 2003 Feb; 133(2):162-9. PubMed ID: 12605177
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma.
Uen YH; Lin SR; Wu CH; Hsieh JS; Lu CY; Yu FJ; Huang TJ; Wang JY
Clin Chim Acta; 2006 May; 367(1-2):55-61. PubMed ID: 16403482
[TBL] [Abstract][Full Text] [Related]
17. [Molecular and cytometric analysis of renal cell carcinoma cells. Concepts, techniques and prospects].
Li G; Lambert C; Gentil-Perret A; Genin C; Tostain J
Prog Urol; 2003 Feb; 13(1):1-13. PubMed ID: 12703348
[TBL] [Abstract][Full Text] [Related]
18. Blood-based RT-PCR assays of MN/CA9 or PSMA: clinical application in renal cancer patients.
de la Taille A; Katz A; Cao Y; McKiernan J; Buttyan R; Burchardt M; Burchardt T; Hayek O; Olsson CA; Chopin DK; Sawczuk IS
Urology; 2000 Sep; 56(3):393-8. PubMed ID: 10962301
[TBL] [Abstract][Full Text] [Related]
19. Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood.
Tong X; Yang L; Lang JC; Zborowski M; Chalmers JJ
Cytometry B Clin Cytom; 2007 Sep; 72(5):310-23. PubMed ID: 17205568
[TBL] [Abstract][Full Text] [Related]
20. Detection of circulating cancer cells in human oral squamous cell carcinoma.
Zen H; Nakashiro K; Shintani S; Sumida T; Aramoto T; Hamakawa H
Int J Oncol; 2003 Sep; 23(3):605-10. PubMed ID: 12888894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
